Evaluating a Novel Onco-genetic BRCA testing Counselling Model Among Patients with Ovarian Cancer

Trial Identifier: D0816R00006
Sponsor: AstraZeneca
Collaborator:
Optum
NCTID:: NCT02406235
Start Date: April 2015
Primary Completion Date: September 2016
Study Completion Date: September 2016
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
ITALY, IT Brescia, IT, ITALY
ITALY, IT Genova, IT, ITALY
ITALY, IT Modena, IT, ITALY
ITALY, IT Napoli, IT, ITALY
ITALY, IT Roma, IT, ITALY
ITALY, IT Torino, IT, ITALY
SPAIN, SP A Coruna, SP, SPAIN
SPAIN, SP Barcelona, SP, SPAIN
SPAIN, SP Caceres, SP, SPAIN
SPAIN, SP Cordoba, SP, SPAIN
SPAIN, SP Madrid, SP, SPAIN
SPAIN, SP Murcia, SP, SPAIN
SPAIN, SP Palma de Mallorca, SP, SPAIN
SPAIN, SP Zaragoza, SP, SPAIN
USA, CA San Francisco, CA, USA
USA, FL Gainesville, FL, USA
USA, FL Sarasota, FL, USA
USA, GA Augusta, GA, USA
USA, MA Worcester, MA, USA
USA, NC Chapel Hill, NC, USA
USA, NY Bronx, NY, USA
USA, NY Hackensack, NY, USA
USA, NY Lake Success, NY, USA
USA, NY Mineola, NY, USA
USA, RI Providence, RI, USA